Insights unfiltered webinar series

Clinical AI in 2030: Building the Future of Clinical Development

Sept. 1 • 9:30 a.m. ET • 3:30 p.m. CET

About the webinar

Clinical AI will define the next era of clinical development. From trial design and analysis to submissions, it's changing how clinical trials are conducted. But only organizations with the right foundation can realize AI’s full potential.

Join SAS experts as they examine the future of clinical AI and what organizations need to do now to prepare. Drawing on real-world perspectives, you'll learn how to build the right foundation and how SAS Clinical Acceleration helps modernize clinical analytics without costly rebuilds.

Attendees will learn:

  • Why clinical AI will change clinical development and what organizations must do to remain competitive.
  • How to build the foundation for trusted, scalable AI through modern data architectures, governance frameworks and interoperable platforms.
  • How generative AI, intelligent agents and modern clinical analytics platforms can boost productivity, shorten drug development timelines and improve business performance.

Have a SAS profile? To complete this form automatically Sign In

*
*
*
*
 
 

All personal information will be handled in accordance with the SAS Privacy Statement.

 
  Yes, I would like to receive occasional emails from SAS and SAS business partners about their products and services. I understand I can withdraw my consent at any time by clicking the opt-out link in the emails.
 
 

About the experts


Mark Lambrecht

Global Head, Health Care and Life Sciences Advisory, SAS

Dr. Mark Lambrecht has more than 20 years of experience studying and implementing the potential, use and future of analytics, artificial intelligence and data engineering to advance patient outcomes. As Global Head of Health Care and Life Sciences Advisory at SAS, he helps organizations develop strategies that leverage trusted data, AI and advanced analytics to accelerate innovation and improve business outcomes across the health care and life sciences ecosystem. Mark frequently advises leaders on how to move AI, real-world evidence and digital health initiatives from hype to reality while navigating clinical, operational and regulatory complexity. Prior to joining SAS, Mark worked in the pharmaceutical industry and studied at KU Leuven in Belgium and Stanford University in the United States. He holds a PhD and a master's degree in bioscience genetic engineering from KU Leuven.


Sudip Gangopadhyay

Global Life Sciences Executive Advisor, SAS

Sudip Gangopadhyay is an accomplished life sciences executive with more than 25 years of global leadership experience spanning R&D, manufacturing, supply chain, patient advocacy, quality, regulatory and digital transformation. Before joining SAS, he served in senior leadership roles at Vertex Pharmaceuticals, Immunomedics, AstraZeneca, Viatris and Pfizer, helping organizations leverage technology, data and AI to drive innovation and business value. At SAS, he advises pharmaceutical and biotechnology organizations on strategies to modernize operations, accelerate drug development and prepare for the future of AI-enabled clinical development.


Cameron McLauchlin

Principal Product Marketing Manager, Health and Life Sciences, SAS

Cameron McLauchlin leads industry product marketing initiatives for the health care and life sciences industries at SAS. In this role, Cameron works closely with industry experts, customers and strategic partners to develop thought leadership, market insights and go-to-market strategies that help organizations unlock value from data, analytics and AI. Prior to joining SAS, Cameron spent 13 years in agency account management, leading marketing, branding and business development initiatives for health care and pharmaceutical clients. Cameron's specialties include strategic planning, persona-driven messaging, and bringing complex industry and technology topics to life for executive audiences. Cameron holds a BA in journalism and mass communication from the University of North Carolina at Chapel Hill.